Pediatric Schizophrenia Efficacy and Safety Study
Clinical trial NCT01911429 · COMPLETED
Trial details
- NCT number
- NCT01911429
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.